Corcept Therapeutics Incorporated monthly returns
Corcept Therapeutics Incorporated has averaged 2.80% a month with dividends reinvested, and risen in 49% of months, through November 17, 2026. The table lists the most recent months; the chart, the last 5 years.
Month by month#
Data provided bySource: Twelve Data| Month | Path | Total return |
|---|---|---|
| Nov 2026 | -13.6% | |
| Oct 2026 | -29.6% | |
| Sep 2026 | +1.7% | |
| Aug 2026 | -1.0% | |
| Jul 2026 | +31.7% | |
| Jun 2026 | +25.1% | |
| May 2026 | +49.4% | |
| Apr 2026 | +15.4% | |
| Mar 2026 | +12.9% | |
| Feb 2026 | -10.5% | |
| Jan 2026 | +14.6% | |
| Dec 2025 | -56.2% | |
| Nov 2025 | +8.1% | |
| Oct 2025 | -11.6% | |
| Sep 2025 | +19.2% | |
| Aug 2025 | +3.8% | |
| Jul 2025 | -8.5% | |
| Jun 2025 | -5.4% | |
| May 2025 | +7.9% | |
| Apr 2025 | -37.1% | |
| Mar 2025 | +88.5% | |
| Feb 2025 | -9.5% | |
| Jan 2025 | +32.8% | |
| Dec 2024 | -12.6% | |
| Nov 2024 | +17.8% | |
| Oct 2024 | +5.8% | |
| Sep 2024 | +31.1% | |
| Aug 2024 | -8.7% | |
| Jul 2024 | +19.0% | |
| Jun 2024 | +7.7% | |
| May 2024 | +29.4% | |
| Apr 2024 | -7.4% | |
| Mar 2024 | +7.2% | |
| Feb 2024 | +11.4% | |
| Jan 2024 | -35.0% | |
| Dec 2023 | +27.5% | |
| Nov 2023 | -9.3% | |
| Oct 2023 | +3.0% | |
| Sep 2023 | -16.7% | |
| Aug 2023 | +28.5% | |
| Jul 2023 | +14.5% | |
| Jun 2023 | -5.3% | |
| May 2023 | +4.3% | |
| Apr 2023 | +4.0% | |
| Mar 2023 | +4.0% | |
| Feb 2023 | -8.9% | |
| Jan 2023 | +12.6% | |
| Dec 2022 | -19.7% | |
| Nov 2022 | -11.6% | |
| Oct 2022 | +11.5% | |
| Sep 2022 | -0.7% | |
| Aug 2022 | -9.9% | |
| Jul 2022 | +20.5% | |
| Jun 2022 | +14.1% | |
| May 2022 | -3.1% | |
| Apr 2022 | -4.5% | |
| Mar 2022 | +1.0% | |
| Feb 2022 | +18.8% | |
| Jan 2022 | -5.2% | |
| Dec 2021 | -5.7% | |
| Nov 2021 | +16.7% | |
| Oct 2021 | -8.5% | |
| Sep 2021 | -7.5% | |
| Aug 2021 | +2.5% | |
| Jul 2021 | -5.6% | |
| Jun 2021 | +1.9% | |
| May 2021 | -5.2% | |
| Apr 2021 | -4.2% | |
| Mar 2021 | -5.4% | |
| Feb 2021 | -11.0% | |
| Jan 2021 | +8.0% | |
| Dec 2020 | +15.5% | |
| Nov 2020 | +34.9% | |
| Oct 2020 | -3.6% | |
| Sep 2020 | +37.1% | |
| Aug 2020 | -15.1% | |
| Jul 2020 | -11.1% | |
| Jun 2020 | +11.1% | |
| May 2020 | +19.6% | |
| Apr 2020 | +6.5% | |
| Mar 2020 | -5.8% | |
| Feb 2020 | -0.4% | |
| Jan 2020 | +4.7% | |
| Dec 2019 | -5.7% | |
| Nov 2019 | -12.1% | |
| Oct 2019 | +3.2% | |
| Sep 2019 | +12.1% | |
| Aug 2019 | +12.0% | |
| Jul 2019 | +1.0% | |
| Jun 2019 | +14.0% | |
| May 2019 | -21.0% | |
| Apr 2019 | +5.5% | |
| Mar 2019 | -5.9% | |
| Feb 2019 | +11.5% | |
| Jan 2019 | -16.3% | |
| Dec 2018 | -4.1% | |
| Nov 2018 | +18.6% | |
| Oct 2018 | -16.2% | |
| Sep 2018 | -6.7% | |
| Aug 2018 | +14.4% | |
| Jul 2018 | -16.5% | |
| Jun 2018 | -15.0% | |
| May 2018 | +10.9% | |
| Apr 2018 | +1.4% | |
| Mar 2018 | +8.3% | |
| Feb 2018 | -34.0% | |
| Jan 2018 | +27.5% | |
| Dec 2017 | +0.7% | |
| Nov 2017 | -8.9% | |
| Oct 2017 | +2.0% | |
| Sep 2017 | +15.8% | |
| Aug 2017 | +33.7% | |
| Jul 2017 | +5.7% | |
| Jun 2017 | +4.3% | |
| May 2017 | +18.6% | |
| Apr 2017 | -13.0% | |
| Mar 2017 | +21.9% | |
| Feb 2017 | +26.4% | |
| Jan 2017 | -2.1% | |
| Dec 2016 | -13.5% |
Monthly total return (since Dec 2021)#
Corcept Therapeutics Incorporated returns by calendar month#
Every month of every year since 2004, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
November 2026 so far: -13.62% — 19th of 23 Novembers since 2004 at the last close; the average November returned +1.9%.
| Month | −100%0+100% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +2.1% | -0.3% | 50% | +51.7% 2013 | -35.0% 2024 | |
| Feb | +0.8% | -1.8% | 41% | +42.5% 2009 | -34.0% 2018 | |
| Mar | +14.0% | +7.5% | 77% | +88.5% 2025 | -18.2% 2007 | |
| Apr | +0.6% | +1.4% | 55% | +72.2% 2007 | -37.1% 2025 | |
| May | +2.5% | +2.8% | 52% | +49.4% 2026 | -48.9% 2014 | |
| Jun | +5.3% | -1.8% | 48% | +97.1% 2007 | -31.1% 2004 | |
| Jul | +0.9% | -5.1% | 48% | +39.5% 2009 | -19.4% 2012 | |
| Aug | -0.7% | -1.0% | 39% | +42.7% 2007 | -67.6% 2006 | |
| Sep | +6.1% | -0.7% | 48% | +52.6% 2007 | -30.6% 2008 | |
| Oct | -2.0% | -1.9% | 48% | +34.7% 2009 | -29.6% 2026 | |
| Nov | +1.9% | +3.9% | 50% | +43.1% 2015 | -42.4% 2012 | |
| Dec | +3.0% | -0.8% | 41% | +49.3% 2013 | -56.2% 2025 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from CORT's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Corcept Therapeutics Incorporated's average monthly return?
- Corcept Therapeutics Incorporated has averaged about 2.80% per month (dividends reinvested), positive in roughly 49% of months. The best month was Jun 2007 (+97.1%) and the worst was Aug 2006 (-67.6%).
